FDA Inspection 1157825 — New York Blood Center Inc

New York Blood Center Inc — FEI 3016373548

The FDA completed an inspection of New York Blood Center Inc on Oct 15, 2021 in Freehold, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Oct 15, 2021
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Freehold, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.